Literature DB >> 2563646

Prostaglandin E2 and alpha 2 adrenoceptor agonists inhibit the pentose phosphate shunt in pancreatic islets.

S G Laychock1.   

Abstract

Glucose utilization in isolated pancreatic islets of the rat was inhibited by prostaglandin (PG) E2 and the alpha 2 adrenoceptor agonist, clonidine, to a similar extent; other prostaglandins did not affect glucose utilization. Islet oxidation of [1-14C]glucose and [6-14C]glucose demonstrated that the pentose phosphate shunt was inhibited by PGE2 and clonidine. Pertussis toxin antagonizes the effects of clonidine and PGE2 on total glucose utilization and pentose phosphate shunt activity. The results suggest that PGE2 and alpha 2 adrenoceptor agonists may regulate glucose metabolism through similar transduction mechanisms, and that a guanine nucleotide binding regulatory (G) protein modulates certain metabolic effects of prostaglandins and adrenergic agonists.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2563646     DOI: 10.1016/0003-9861(89)90117-3

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  4 in total

1.  Islet adaptations in fetal sheep persist following chronic exposure to high norepinephrine.

Authors:  Xiaochuan Chen; Amy C Kelly; Dustin T Yates; Antoni R Macko; Ronald M Lynch; Sean W Limesand
Journal:  J Endocrinol       Date:  2016-11-25       Impact factor: 4.286

2.  Alpha 2-adrenergic stimulation counteracts glucose-induced rise of sodium in pancreatic islets exposed to ouabain.

Authors:  S Saha; B Hellman
Journal:  Acta Diabetol       Date:  1995-06       Impact factor: 4.280

3.  Evaluation of the pentose phosphate pathway from 14CO2 data. Fallibility of a classic equation when applied to non-homogeneous tissues.

Authors:  M G Larrabee
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

4.  Prostaglandin E2 inhibits phosphoinositide metabolism in isolated pancreatic islets.

Authors:  S G Laychock
Journal:  Biochem J       Date:  1989-05-15       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.